Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma

Jiang-Tao LIN; Ping CHEN; Xin ZHOU; Tie-Ying SUN; Can-Mao XIE; Qing-Yu XIU; Wan-Zhen YAO; Lan YANG; Kai-Sheng YIN; Yong-Ming ZHANG.
Chinese Medical Journal ; (24): 2994-3001, 2012.
Artículo en Inglés | WPRIM | ID: wpr-316580

Documentos relacionados

  1. Budesonide/formoterol maintenance and reliever therapy in Chinese patients with asthma.
  2. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
  3. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.
  4. Self-titration of inhaled corticosteroid and ß<sub>2</sub>-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial.
  5. Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial.
  6. The management of mild asthma.
  7. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
  8. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
  9. Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
  10. SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis.